627 results on '"Chen, Zhe-Sheng"'
Search Results
2. Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma
3. Correction: Bridging cultures: Chinese elements in scientific illustrations
4. Research progress of antibody–drug conjugates in gynecologic cancer
5. Bridging cultures: Chinese elements in scientific illustrations
6. Understanding the Novel Approach of Nanoferroptosis for Cancer Therapy
7. A novel nitric oxide-driven nanomotor for synergistic treatment of ischaemic stroke: Enhanced deep brain penetration and therapeutic efficacy
8. Nanotechnology-based delivery systems to overcome drug resistance in cancer
9. Dostarlimab in the treatment of mismatch repair deficient recurrent or advanced endometrial cancer
10. Synthesis and clinical application of new drugs approved by FDA in 2022
11. Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer
12. Epigenetic modification of m6A regulator proteins in cancer
13. Gold nanoparticles and gold nanorods in the landscape of cancer therapy
14. Stellettin B renders glioblastoma vulnerable to poly (ADP-ribose) polymerase inhibitors via suppressing homology-directed repair
15. Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies
16. Advancements in nanoparticle-based treatment approaches for skin cancer therapy
17. New opportunities for RGD-engineered metal nanoparticles in cancer
18. Targeting autophagy to counteract neuroinflammation: A novel antidepressant strategy
19. Design, synthesis, and biological evaluation of phenylurea indole derivatives as ABCG2 inhibitors
20. Cancer nuclear envelope rupture and repair in taxane resistance
21. NAT10 Promotes Prostate Cancer Growth and Metastasis by Acetylating mRNAs of HMGA1 and KRT8.
22. PIK3CA mutations-mediated downregulation of circLHFPL2 inhibits colorectal cancer progression via upregulating PTEN
23. PBK/TOPK inhibitor OTS964 resistance is mediated by ABCB1-dependent transport function in cancer: in vitro and in vivo study
24. m6A modification: recent advances, anticancer targeted drug discovery and beyond
25. Methyltransferase like 7B is a potential therapeutic target for reversing EGFR-TKIs resistance in lung adenocarcinoma
26. Signaling pathways and therapeutic interventions in gastric cancer
27. N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer
28. CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells
29. Microbiota in health and diseases
30. Proteomics technologies for cancer liquid biopsies
31. Targeting HNRNPU to overcome cisplatin resistance in bladder cancer
32. Gut microbes regulate the feeding center: a new discovery of Gut Brain Axis
33. Redox signaling-governed drug-tolerant persister cancer cell: a key spark of treatment failure
34. Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer
35. Isolation, bioassay and 3D-QSAR analysis of 8-isopentenyl flavonoids from Epimedium sagittatum maxim. as PDE5A inhibitors
36. Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p
37. Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma
38. Next‐generation spatial transcriptomics: unleashing the power to gear up translational oncology.
39. Actin-related protein 2/3 complex subunit 1B promotes ovarian cancer progression by regulating the AKT/PI3K/mTOR signaling pathway.
40. A pilot trial of neoadjuvant pyrotinib plus trastuzumab, dalpiciclib, and letrozole for triple‐positive breast cancer
41. CUL4high Lung Adenocarcinomas Are Dependent on the CUL4-p21 Ubiquitin Signaling for Proliferation and Survival
42. Bypassing P-glycoprotein mediated efflux of afatinib by cyclodextrin complexation – Evaluation of intestinal absorption and anti-cancer activity
43. Overexpression of human ATP-binding cassette transporter ABCG2 contributes to reducing the cytotoxicity of GSK1070916 in cancer cells
44. Research progress of traditional Chinese medicine influencing macrophage polarization
45. Repurposing FDA-approved drugs for SARS-CoV-2 through an ELISA-based screening for the inhibition of RBD/ACE2 interaction
46. Glutathione‐Sensitive Photosensitizer–Drug Conjugates Target the Mitochondria to Overcome Multi‐Drug Resistance in Cancer.
47. RN486, a Bruton's Tyrosine Kinase inhibitor, antagonizes multidrug resistance in ABCG2-overexpressing cancer cells.
48. Combating antimicrobial resistance: the silent war
49. Characterization of the Nucleus Pulposus Progenitor Cells via Spatial Transcriptomics
50. Therapeutic evolution in HR+/HER2- breast cancer: from targeted therapy to endocrine therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.